Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)-Reference-Cited by-同舟云学术

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)

Published:2023-03-19 Issue:1 Volume:22 Page:288-298
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Maeda Haruka¹²,Saito Nobuo³,Igarashi Ataru⁴⁵,Ishida Masayuki⁶,Terada Mayumi⁷,Ito Takayasu⁸⁹,Ikeda Hideko¹⁰,Kamura Hiroshi¹¹,Motohashi Iori¹²,Kimura Yuya¹³,Komino Masaru¹⁴,Arai Hiromi¹⁴,Kuwamitsu Osamu¹⁵,Akuzawa Nobuhiro¹⁶,Sando Eiichiro¹⁷¹⁸,Morikawa Toru¹⁹,Imura Haruki²⁰,Inoue Hiroki²⁰,Hayakawa Tomoichiro²¹,Teshigahara Osamu²²,Ohara Yasuji²³,Suzuki Motoi²⁴,Morimoto Konosuke¹

Affiliation:

1. Department of Respiratory Infections, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan

2. Department of Clinical Tropical Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

3. Department of Microbiology, Faculty of Medicine, Oita University, Oita, Japan

4. Department of Public Health, Yokohama City University School of Medicine, Kanagawa, Japan

5. Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan

6. Department of Infectious Disease Medicine, Chikamori Hospital, Kochi, Japan

7. Department of Internal Medicine, Nijigaoka Hospital, Nagasaki, Japan

8. Department of Emergency Medicine, Toyota Kosei Hospital, Aichi, Japan

9. Department of Clinical Training and Career Development, Gifu University, Gifu, Japan

10. Department of Nursing, Toyota Kosei Hospital, Aichi, Japan

11. Loco Clinic Nakameguro, Tokyo, Japan

12. Department of General Internal Medicine, Kawasaki Municipal Tama Hospital, Kanagawa, Japan

13. Department of Cardiology, Saiseikai Kazo Hospital, Saitama, Japan

14. Department of Nursing, Saiseikai Kazo Hospital, Saitama, Japan

15. Gohongi Clinic, Tokyo, Japan

16. Department of Internal Medicine, Gunma Chuo Hospital, Gunma, Japan

17. Department of General Internal Medicine and Clinical Infectious Diseases, Kita-Fukushima Medical Center, Fukushima, Japan

18. Department of General Internal Medicine and Clinical Infectious Diseases, Fukushima Medical University, Fukushima, Japan

19. Department of General Medicine, Nara City Hospital, Nara, Japan

20. Department of Infectious Disease Medicine, Rakuwakai Otowa Hospital, Kyoto, Japan

21. Hayakawa Internal Medicine Clinic, Fukuoka, Japan

22. Mizuho Street Clinic, Aichi, Japan

23. Department of Internal Medicine, Takagi Hospital, Aichi, Japan

24. Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan

Funder

Japan Agency for Medical Research and Development

Ministry of Health, Labour and Welfare

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2188950

Reference40 articles.

1. National Institute of Infectious Diseases. COVID-19 vaccine (as of May 10 2021). Availabel at: https://www.niid.go.jp/niid/images/vaccine/covid19_vaccine_20210510.pdf. Accessed 2022 Dec 4

2. Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)

3. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

4. Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

5. Waning Immunity after the BNT162b2 Vaccine in Israel

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of COVID-19 mRNA vaccine in preventing infection against Omicron strain: Findings from the Hiroshima Prefecture COVID-19 version J-SPEED for PCR center;PLOS Global Public Health;2024-04-17

2. Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan;Human Vaccines & Immunotherapeutics;2024-03-22

3. Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan;Expert Review of Vaccines;2024-03-05

4. Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS);Expert Review of Vaccines;2024-02-08

5. The mRNA Vaccination Rate Is Negatively and the Proportion of Elderly Individuals Is Positively Associated With the Excess Mortality Rate After 2020 in Japan;Cureus;2024-01-18